(-0.10%) 5 302.75 points
(-0.03%) 40 130 points
(-0.18%) 18 471 points
(0.63%) $81.86
(-1.40%) $1.694
(0.16%) $2 216.30
(-0.77%) $24.56
(-0.15%) $908.30
(0.49%) $0.928
(0.78%) $10.85
(0.36%) $0.794
(-0.15%) $92.30
Live Chart Being Loaded With Signals
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide...
Stats | |
---|---|
Today's Volume | 660 000 |
Average Volume | 1.93M |
Market Cap | 11.85M |
EPS | $0 ( 2024-02-25 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.500 |
ATR14 | $0 (0.00%) |
Oncosil Medical Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Oncosil Medical Ltd Financials
Annual | 2023 |
Revenue: | $367 677 |
Gross Profit: | $-6.49M (-1 766.30 %) |
EPS: | $-0.0100 |
Q2 | 2023 |
Revenue: | $87 956.00 |
Gross Profit: | $-3.22M (-3 665.66 %) |
EPS: | $-0.00300 |
Q4 | 2023 |
Revenue: | $151 352 |
Gross Profit: | $-3.43M (-2 266.03 %) |
EPS: | $-0.00430 |
Q3 | 2022 |
Revenue: | $328 917 |
Gross Profit: | $-186 673 (-56.75 %) |
EPS: | $-0.00220 |
Financial Reports:
No articles found.
Oncosil Medical Ltd
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators